Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 327

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Incidence of and Risk Factors for Colistin-Associated Nephrotoxicity in a Large Academic Health System

Open access
Pogue, J. M., Lee, J., Marchaim, D., Yee, V., Zhao, J. J., Chopra, T., Lephart, P., Kaye, K. S.·2011·Clinical Infectious Diseases

Abstract

Background.Colistin, originally abandoned due to high rates of nephrotoxicity, has been recently reintroduced due to activity against carbapenem-resistant Gram-negative organisms.Recent literature, largely obtained from outside the United States, suggests a lower rate of nephrotoxicity than historically reported. Methods.A retrospective cohort of all patients who received colistin for $48 hours at the Detroit Medical Center over a 5-year period was performed to determine the rate of colistin-associated nephrotoxicity as defined by the RIFLE criteria.Results.Fifty-four (43%) patients in the cohort developed nephrotoxicity.Patients who experienced nephrotoxicity after colistin administration were in the Risk (13%), Injury (17%), or Failure (13%) categories per RIFLE criteria.Patients who developed nephrotoxicity received significantly higher mean doses than those who did not (5.48 mg/kg per day vs 3.95 mg/kg per day; P , .001), and the toxicity occurred in a dose-dependent fashion.Independent predictors for nephrotoxicity were a colistin dose of $5.0 mg/kg per day of ideal body weight (odds ratio [OR], 23.41; 95% confidence interval [CI], 5.3-103.55),receipt of concomitant rifampin (OR, 3.81; 95% CI, 1.42-10.2),and coadministration of $3 concomitant nephrotoxins (OR, 6.80; 95% CI, 1.42-32.49). Conclusions.In this retrospective cohort, nephrotoxicity (as defined by RIFLE criteria) occurred among 43% of treated patients in a dose-dependent manner.Higher colistin doses, similar to those commonly used in the United States, led to a relatively high rate of nephrotoxicity.These data raise important questions regarding the safe use of colistin in the treatment of multidrug-resistant pathogens.Colistin, a polymyxin antimicrobial agent, was originally used in the 1960s, but due to nephrotoxicity rates approaching 50%, it was abandoned as other ''less toxic'' antimicrobials became available [1].Colistin has recently reemerged as a last line therapeutic agent for the treatment of multidrug-resistant pathogens including Acinetobacter baumannii, Pseudomonas aeruginosa, and carbapenem-resistant Enterobacteriaceae.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cid/cir611

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 327

Metadata

Authors
Pogue, J. M., Lee, J., Marchaim, D., Yee, V., Zhao, J. J., Chopra, T., Lephart, P., & Kaye, K. S.
Venue
Clinical Infectious Diseases
Published
2011-09-07
Volume
53
Issue
9
Pages
879-884
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2162268639
Cited by
327
References
18
FWCI
12.28
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Incidence of and Risk Factors for Colistin-Associated Nephrotoxicity in a Large Academic Health System. https://app.cochat.ai/papers/10.1093/cid/cir611
The paper
Pogue, J. M., Lee, J., Marchaim, D., Yee, V., Zhao, J. J., Chopra, T., Lephart, P., & Kaye, K. S. (2011). Incidence of and Risk Factors for Colistin-Associated Nephrotoxicity in a Large Academic Health System. Clinical Infectious Diseases. https://doi.org/10.1093/cid/cir611

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.